Only 7.35% of the cases had KIF11 overexpression, whereby this expression pattern included patients whose tumors simultaneously exhibited high KIF11 staining intensity (mostly strong 3+ staining) on at least 25–49% of tumor cells. Here, KIF11 is linked to neoplasm.